Barely Significant
← all excerpts

Performance of HPV genotyping and <i>GYPC</i> methylation as a triage strategy for HPV-positive women with normal or minimal cytological findings.

Front Med (Lausanne) · 2025 · PMC12043468 · PMID 40313561

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

a decreasing trendp < 0.001actually significant
Four combinations of HPV16/18 and HPV16/18/33/35/58 with GYPC m testing—(+) (+), (−) (+), (+) (−), and (−) (−)—showed a decreasing trend in absolute CIN2 + risk ( p < 0.001).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.